The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring.
Open accessAbstract
Low birth weight in humans is predictive of insulin resistance and diabetes in adult life.The molecular mechanisms underlying this link are unknown but fetal exposure to excess glucocorticoids has been implicated.The fetus is normally protected from the higher maternal levels of glucocorticoids by feto-placental 11  -hydroxysteroid dehydrogenase type-2 (11  -HSD2) which inactivates glucocorticoids.We have shown previously that inhibiting 11  -HSD2 throughout pregnancy in rats reduces birth weight and causes hyperglycemia in the adult offspring.We now show that dexamethasone (a poor substrate for 11  -HSD2) administered to pregnant rats selectively in the last week of pregnancy reduces birth weight by 10% ( P Ͻ 0.05), and produces adult fasting hyperglycemia (treated 5.3 Ϯ 0.3; control 4.3 Ϯ 0.2 mmol/ liter, P ϭ 0.04), reactive hyperglycemia (treated 8.7 Ϯ 0.4; control 7.5 Ϯ 0.2 mmol/liter, P ϭ 0.03), and hyperinsulinemia (treated 6.1 Ϯ 0.4; control 3.8 Ϯ 0.5 ng/ml, P ϭ 0.01) on oral glucose loading.In the adult offspring of rats exposed to dexamethasone in late pregnancy, hepatic expression of glucocorticoid receptor (GR) mRNA and phosphoenolpyruvate carboxykinase (PEPCK) mRNA (and activity) are increased by 25% ( P ϭ 0.01) and 60% ( P Ͻ 0.01), respectively, while other liver enzymes (glucose-6-phosphatase, glucokinase, and 11  -hydroxysteroid dehydrogenase type-1) are unaltered.In contrast dexamethasone, when given in the first or second week of gestation, has no effect on offspring insulin/glucose responses or hepatic PEPCK and GR expression.The increased hepatic GR expression may be crucial, since rats exposed to dexamethasone in utero showed potentiated glucose responses to exogenous corticosterone.These observations suggest that excessive glucocorticoid exposure late in pregnancy predisposes the offspring to glucose intolerance in adulthood.Programmed hepatic PEPCK overexpression, perhaps mediated by increased GR, may promote this process by increasing gluconeogenesis.( J.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simplification of the protein assay method of Lowry et al. which is more generally applicable
Peterson, G. L. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90043-4 · Cited by 8,524
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
Hales, C. N., & Barker, D. J. P. (1992) · Diabetologia · doi:10.1007/bf00400248 · Cited by 3,309
Fetal nutrition and cardiovascular disease in adult life
Barker, D. J. P., Godfrey, K. M., Gluckman, P. D., Harding, J. E., Owens, J. A., & Robinson, J. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91224-a · Cited by 2,753
Fetal and infant growth and impaired glucose tolerance at age 64
Hales, C. N., Barker, D. J., Clark, P. M., Cox, L. J., Fall, C., Osmond, C., & Winter, P. D. (1991) · BMJ · doi:10.1136/bmj.303.6809.1019 · Cited by 2,708
Fetal and placental size and risk of hypertension in adult life.
Barker, D. J., Bull, A. R., Osmond, C., & Simmonds, S. J. (1990) · BMJ · doi:10.1136/bmj.301.6746.259 · Cited by 1,728
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Effect of Neonatal Handling on Age-Related Impairments Associated with the Hippocampus
Meaney, M. J., Aitken, D. H., van Berkel, C., Bhatnagar, S., & Sapolsky, R. M. (1988) · Science · doi:10.1126/science.3340858 · Cited by 1,074
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“Since PEPCK is the rate limiting enzyme of gluconeogenesis (43), and overexpression of PEPCK in a rat hepatoma cell line impairs suppression of gluconeogenesis (44), it is plausible that increased PEPCK in vivo potentiates hepatic glucose production, producing the observed glucose intolerance.”
BackgroundKotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Self-citationType 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
Hales, C., & Barker, D. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt133 · Cited by 708
Cited by
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708473 · Cited by 3,898
Developmental Origins of the Metabolic Syndrome: Prediction, Plasticity, and Programming
Mcmillen, I. C., & Robinson, J. S. (2005) · Physiological Reviews · doi:10.1152/physrev.00053.2003 · Cited by 1,910
The long-term behavioural consequences of prenatal stress
Weinstock, M. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.002 · Cited by 1,052
Prenatal stress, glucocorticoids and the programming of the brain
Welberg, L. A. M., & Seckl, J. R. (2001) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2001.00601.x · Cited by 928
Self-citation11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Self-citationGlucocorticoids, prenatal stress and the programming of disease
Harris, A., & Seckl, J. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.06.007 · Cited by 871
Self-citationPrenatal glucocorticoids and long-term programming
Seckl (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u049 · Cited by 825
Seckl, J. R., & Holmes, M. C. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0515 · Cited by 754
Self-citationClayton, P. E., Cianfarani, S., Czernichow, P., Johannsson, G., Rapaport, R., & Rogol, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2017 · Cited by 747
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
Predictive adaptive responses and human evolution
Gluckman, P. D., Hanson, M. A., & Spencer, H. G. (2005) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2005.08.001 · Cited by 713
Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health
Meaney, M. J., Szyf, M., & Seckl, J. R. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.05.003 · Cited by 668
Self-citationFetal Origins of Adult Disease
Calkins, K., & Devaskar, S. U. (2011) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2011.01.001 · Cited by 651
Prenatal stress, glucocorticoids and the programming of adult disease
Cottrell, E. C. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.019.2009 · Cited by 640
“…plausibly driving the observed increase in both the expression and activity of the gluconeogenic enzyme phosphoenolypyruvate carboyxkinase (PEPCK), and programming insulin resistance and impaired glucose tolerance in adult life (Hales et al., 1996; Ozanne et al., 1996; Nyirenda et al., 1998).”
BackgroundInfluentialThe developmental origins of adult disease (Barker) hypothesis
DE BOO, H. A., & HARDING, J. E. (2006) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2006.00506.x · Cited by 630
Endocrine disrupters as obesogens
Grün, F., & Blumberg, B. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.018 · Cited by 582
Transgenerational Epigenetic Effects
Youngson, N. A., & Whitelaw, E. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164445 · Cited by 580
Lillycrop, K. A., Slater-Jefferies, J. L., Hanson, M. A., Godfrey, K. M., Jackson, A. A., & Burdge, G. C. (2007) · British Journal of Nutrition · doi:10.1017/s000711450769196x · Cited by 564
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
SECKL, J. R., & MEANEY, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.006 · Cited by 556
Self-citationJansson, T., & Powell, T. L. (2007) · Clinical Science · doi:10.1042/cs20060339 · Cited by 542
Endocrine mechanisms of intrauterine programming
Fowden, A. L., & Forhead, A. J. (2004) · Reproduction · doi:10.1530/rep.1.00033 · Cited by 471
Drake, A., & Walker, B. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1800001 · Cited by 430
Welberg, L. A. M., Seckl, J. R., & Holmes, M. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00065-3 · Cited by 420
Self-citationSheng, J. A., Bales, N. J., Myers, S. A., Bautista, A. I., Roueinfar, M., Hale, T. M., & Handa, R. J. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.601939 · Cited by 418
Maternal stress alters endocrine function of the feto-placental unit in rats
Mairesse, J., Lesage, J., Breton, C., Bréant, B., Hahn, T., Darnaudéry, M., Dickson, S. L., Seckl, J., Blondeau, B., Vieau, D., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00574.2006 · Cited by 410
Self-citationIntergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats
Drake, A. J., Walker, B. R., & Seckl, J. R. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00106.2004 · Cited by 410
Self-citationGlucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms
Seckl, J. R. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00633-5 · Cited by 392
Self-citationLesage, J., Blondeau, B., Grino, M., Bréant, B., & Dupouy, J. P. (2001) · Endocrinology · doi:10.1210/endo.142.5.8139 · Cited by 379
Gender-linked hypertension in offspring of lard-fed pregnant rats
Khan, I. Y., Taylor, P. D., Dekou, V., Seed, P. T., Lakasing, L., Graham, D., Dominiczak, A. F., Hanson, M. A., & Poston, L. (2003) · Hypertension · doi:10.1161/01.hyp.0000047511.97879.fc · Cited by 365
Stress and obesity: the role of the hypothalamic–pituitary–adrenal axis in metabolic disease
Bose, M., Oliván, B., & Laferrère, B. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832fa137 · Cited by 358
Bertram, C., Trowern, A. R., Copin, N., Jackson, A. A., & Whorwood, C. B. (2001) · Endocrinology · doi:10.1210/endo.142.7.8238 · Cited by 351
Welberg, L. A. M., Seckl, J. R., & Holmes, M. C. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00958.x · Cited by 348
Self-citationPlagemann, A., Harder, T., Rake, A., Voits, M., Fink, H., Rohde, W., & Dörner, G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01662-5 · Cited by 331
The fetal, neonatal, and infant environments-the long-term consequences for disease risk
Gluckman, P. D., Cutfield, W., Hofman, P., & Hanson, M. A. (2005) · Early Human Development · doi:10.1016/j.earlhumdev.2004.10.003 · Cited by 326
Duthie, L., & Reynolds, R. M. (2013) · Neuroendocrinology · doi:10.1159/000354702 · Cited by 326
Burdge, G. C., Hanson, M. A., Slater-Jefferies, J. L., & Lillycrop, K. A. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507682920 · Cited by 323
Reynolds, R. M., Walker, B. R., Syddall, H. E., Andrew, R., Wood, P. J., Whorwood, C. B., & Phillips, D. I. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7145 · Cited by 322
Beijers, R., Buitelaar, J. K., & de Weerth, C. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0566-3 · Cited by 317
Mechanisms involved in the developmental programming of adulthood disease
Warner, M. J., & Ozanne, S. E. (2010) · Biochemical Journal · doi:10.1042/bj20091861 · Cited by 316
Grün, F., & Blumberg, B. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9049-x · Cited by 305
Early-life stress, HPA axis adaptation, and mechanisms contributing to later health outcomes
Maniam, J., Antoniadis, C., & Morris, M. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00073 · Cited by 295
Animal models and programming of the metabolic syndrome
Bertram, C. E., & Hanson, M. A. (2001) · British Medical Bulletin · doi:10.1093/bmb/60.1.103 · Cited by 295
Prenatal Stress or High-Fat Diet Increases Susceptibility to Diet-Induced Obesity in Rat Offspring
Tamashiro, K. L. K., Terrillion, C. E., Hyun, J., Koenig, J. I., & Moran, T. H. (2009) · Diabetes · doi:10.2337/db08-1129 · Cited by 291
Lesage, J., Del-Favero, F., Leonhardt, M., Louvart, H., Maccari, S., Vieau, D., & Darnaudery, M. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810291 · Cited by 274
Levitt, N. S., Lambert, E. V., Woods, D., Hales, C. N., Andrew, R., & Seckl, J. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7039 · Cited by 270
Self-citationMcCormick, J. A. (2000) · Molecular Endocrinology · doi:10.1210/me.14.4.506 · Cited by 265
Glucocorticoids, developmental ‘programming’ and the risk of affective dysfunction
Seckl, J. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)67002-2 · Cited by 245
Self-citation11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
“Crucially, inhibition, deficiency or by-pass (poor substrate steroids such as dexamethasone or betamethasone) of 11b-HSD2 in gestation in rodents and humans associates with alterations in pregnancy duration, birth weight and programmed outcomes in the offspring [21,48,101,150,188,195,198,200,255,298,299,306,307].”
Self-citationGlucocorticoid “Programming” and PTSD Risk
SECKL, J. R., & MEANEY, M. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.027 · Cited by 234
Self-citationKing, S., Dancause, K., Turcotte‐Tremblay, A., Veru, F., & Laplante, D. P. (2012) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.21026 · Cited by 232
“Recent research has explored the role that maternal stress and/or anxiety during pregnancy has on the subsequent development of behavioral problems during childhood (O’Connor et al., 2003).”
BackgroundMechanisms of disease: the developmental origins of disease and the role of the epigenotype
Ozanne, S. E., & Constância, M. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0531 · Cited by 232
Braun, T., Challis, J. R., Newnham, J. P., & Sloboda, D. M. (2013) · Endocrine Reviews · doi:10.1210/er.2013-1012 · Cited by 196
Minireview: The Case for Obesogens
Grün, F., & Blumberg, B. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0485 · Cited by 188
Role of the hypothalamic–pituitary–adrenal axis in developmental programming of health and disease
Xiong, F., & Zhang, L. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.11.002 · Cited by 177
Prenatal cytokine exposure results in obesity and gender-specific programming
Dahlgren, J., Nilsson, C., Jennische, E., Ho, H.-P., Eriksson, E., Niklasson, A., Björntorp, P., Wikland, K. A., & Holmäng, A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e326 · Cited by 172
Altered Placental Function of 11β-Hydroxysteroid Dehydrogenase 2 Knockout Mice
Wyrwoll, C. S., Seckl, J. R., & Holmes, M. C. (2009) · Endocrinology · doi:10.1210/en.2008-1100 · Cited by 169
Self-citationVarcoe, T. J., Wight, N., Voultsios, A., Salkeld, M. D., & Kennaway, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018504 · Cited by 147
“Unlike synthetic glucocorticoid administration [33,34,35], there is less evidence that prenatal stress exposure alters metabolic homeostasis in the offspring.”
BackgroundLife-long echoes–a critical analysis of the developmental origins of adult disease model
Gluckman, P. D., Hanson, M. A., Morton, S. M. B., & Pinal, C. S. (2005) · Neonatology · doi:10.1159/000082311 · Cited by 126
Foetal and placental 11 β‐HSD 2: a hub for developmental programming
Cottrell, E. C., Seckl, J. R., Holmes, M. C., & Wyrwoll, C. S. (2014) · Acta Physiologica · doi:10.1111/apha.12187 · Cited by 123
Self-citationReconciling the nutritional and glucocorticoid hypotheses of fetal programming
Cottrell, E. C., Holmes, M. C., Livingstone, D. E., Kenyon, C. J., & Seckl, J. R. (2012) · The FASEB Journal · doi:10.1096/fj.12-203489 · Cited by 102
Self-citationDrake, A. J., Raubenheimer, P. J., Kerrigan, D., McInnes, K. J., Seckl, J. R., & Walker, B. R. (2010) · Endocrinology · doi:10.1210/en.2009-1088 · Cited by 97
Self-citationEarly life factors and type 2 diabetes mellitus
Jiang, X., Ma, H., Wang, Y., & Liu, Y. (2013) · Journal of Diabetes Research · doi:10.1155/2013/485082 · Cited by 92
“Studies from animalmodels have found that prenatal glucocorticoids treatment leads to increased hepatic gene expression of hepatocyte nuclear factor 4 alpha [85], phosphoenolpyruvate carboxykinase [86], and glucose-6-phosphatase [87] in the offspring, indicating elevated hepatic gluconeogenesis and hepatic insulin res…”
BackgroundFetal origins of the metabolic syndrome
Xita, N., & Tsatsoulis, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05658.x · Cited by 96
Maccari, S., Polese, D., Reynaert, M.-L., Amici, T., Morley-Fletcher, S., & Fagioli, F. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.042 · Cited by 87
De Blasio, M. J., Dodic, M., Jefferies, A. J., Moritz, K. M., Wintour, E. M., & Owens, J. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00689.2006 · Cited by 84
Varcoe, T. J., Boden, M. J., Voultsios, A., Salkeld, M. D., Rattanatray, L., & Kennaway, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053800 · Cited by 78
Maternal corticosterone regulates nutrient allocation to fetal growth in mice
Vaughan, O. R., Sferruzzi‐Perri, A. N., & Fowden, A. L. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.239426 · Cited by 75
Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation
Davis, E. P., Waffarn, F., Uy, C., Hobel, C. J., Glynn, L. M., & Sandman, C. A. (2009) · Journal of Perinatology · doi:10.1038/jp.2009.85 · Cited by 72
Iqbal, M., Moisiadis, V. G., Kostaki, A., & Matthews, S. G. (2012) · Endocrinology · doi:10.1210/en.2012-1054 · Cited by 72
Prenatal treatment of congenital adrenal hyperplasia
Lajic, S., Nordenstrom, A., Ritzen, E., & Wedell, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u063 · Cited by 67
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Miller, W. L., & Witchel, S. F. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.885 · Cited by 62
Fetal Growth Restriction and Postnatal Development
ELEFTHERIADES, M., CREATSAS, G., & NICOLAIDES, K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.047 · Cited by 60
Witchel, S. F., & DeFranco, D. B. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0323 · Cited by 58
Correia-Branco, A., Keating, E., & Martel, F. (2015) · Reproductive Sciences · doi:10.1177/1933719114542012 · Cited by 55
Molecular mechanisms governing offspring metabolic programming in rodent models of in utero stress
Christoforou, E. R., & Sferruzzi-Perri, A. N. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03566-z · Cited by 44
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Gomes, P. R., Graciano, M. F., Pantaleão, L. C., Rennó, A. L., Rodrigues, S. C., Velloso, L. A., Latorraca, M. Q., Carpinelli, A. R., Anhê, G. F., & Bordin, S. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00364.2013 · Cited by 27
Rogers, S. L., Hughes, B. A., Jones, C. A., Freedman, L., Smart, K., Taylor, N., Stewart, P. M., Shackleton, C. H. L., Krone, N. P., Blissett, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3254 · Cited by 25
Zulkafli, I. S., Waddell, B. J., & Mark, P. J. (2013) · Endocrinology · doi:10.1210/en.2013-1153 · Cited by 22
Prenatal Glucocorticoids: Short-Term Benefits and Long-Term Risks
Manojlovic-Stojanoski, M., Nestorovic, N., & Milosevic, V. (2012) · Glucocorticoids - New Recognition of Our Familiar Friend · doi:10.5772/51106 · Cited by 19
Mark, P. J., Wyrwoll, C. S., Zulkafli, I. S., Mori, T. A., & Waddell, B. J. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-39 · Cited by 19
Metadata
- Authors
- Nyirenda, M. J., Lindsay, R. S., Kenyon, C. J., Burchell, A., & Seckl, J. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-05-15
- Volume
- 101
- Issue
- 10
- Pages
- 2174-2181
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2055001133
- Cited by
- 574
- References
- 60
- FWCI
- 20.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.